Workflow
金信价值精选混合A
icon
Search documents
【机构调研记录】金信基金调研德赛西威
Sou Hu Cai Jing· 2025-11-20 00:14
Group 1 - The core viewpoint of the article highlights the recent research conducted by Jinxin Fund on Desay SV, emphasizing the impact of intelligent driving regulations on the automotive industry, leading to higher performance and safety requirements for vehicle configurations [1] - Desay SV has secured new project orders from international automotive companies such as Toyota, Stellantis, and Volkswagen, indicating strong demand for its products [1] - The company's German factory is operating normally, while the Spanish factory is expected to be completed by the end of this year, with supply starting in 2026 [1] - Desay SV has launched a robotic intelligent base ICube, which applies automotive-grade redundant design to robotic scenarios, enhancing durability and reliability, and supporting rapid model deployment and computational optimization [1] Group 2 - Jinxin Fund, established in 2015, has an asset management scale of 15.995 billion yuan, ranking 131 out of 211 in total public funds [2] - The fund's non-monetary public fund asset management scale is 13.324 billion yuan, ranking 115 out of 211 [2] - Jinxin Fund manages 47 public funds, ranking 109 out of 211, with 8 public fund managers, ranking 116 out of 211 [2] - The best-performing public fund product in the past year is Jinxin Value Selection Mixed A, with a latest unit net value of 1.69 and a growth of 49.26% over the past year [2] - The latest public fund product launched is Jinxin CSI Interbank Certificate of Deposit AAA Index 7-Day Holding, which is an index-type fixed income fund, with a subscription period from November 19, 2025, to December 2, 2025 [2]
5月份超七成混基正收益 华宝医药生物混合A涨11.5%
Zhong Guo Jing Ji Wang· 2025-06-03 23:40
Core Viewpoint - In May 2025, over 70% of the 8,451 comparable mixed funds experienced net value increases, indicating a positive trend in the market [1] Fund Performance Summary - A total of 54 mixed funds achieved a monthly increase of over 10%, with Jinxin Value Selected Mixed A and C leading at 19.38% and 19.36% respectively [2] - Jinxin Value Selected Mixed A and C, established on September 1, 2017, reported year-to-date returns of 32.65% and 32.60%, and cumulative returns of 48.85% and 49.57% as of May 30, 2025 [2] - The top ten holdings of Jinxin Value Selected Mixed A and C focus on the pharmaceutical and biotechnology sectors, particularly in innovative industries [2] - Huabao Pharmaceutical and Biological Mixed A achieved a monthly increase of 11.49%, with a year-to-date return of 41.55% and a cumulative return of 381.22% since its inception [3] Fund Decline Summary - 15 mixed funds saw declines exceeding 10% in May, with Furong Fuxin Mixed C and A at the bottom with -12.39% and -12.38% respectively [4] - Furong Fuxin Mixed C and A focus on humanoid robotics, with their top holdings including Huachen Equipment and Qinchuan Machine Tool [4] Fund Manager Insights - The current fund manager for Jinxin Value Selected Mixed A and C is Zhao Haoran, who has a background in financial research and joined Jinxin Fund in August 2022 [2] - Huabao Pharmaceutical and Biological Mixed A is managed by Zhang Jintao, who has extensive experience in investment research across various financial institutions [3] - Furong Fuxin Mixed C and A are co-managed by Li Yanzheng and Mao Yunhong, both of whom have significant experience in research and fund management [4]